title: Histopathological features of cutaneous drug reactions to vemurafenib:  a report of two cases.
authors.forename: Marcus
authors.initials: M
authors.lastname: Dabner
authors.forename: Nathan T
authors.initials: NT
authors.lastname: Harvey
authors.forename: Anita
authors.initials: A
authors.lastname: Soma
authors.forename: Benjamin A
authors.initials: BA
authors.lastname: Wood
mesh_terms: D000328:Adult; D001706:Biopsy; D003875:Drug Eruptions / Q000473:pathology*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011446:Prospective Studies; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf